Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital

ABSTRACT

Background: More than one-third of COVID-19 patients present neurological symptoms ranging from anosmia to stroke and encephalopathy. Furthermore, pre-existing neurological conditions may require special treatment and may be associated with worse outcomes. Notwithstanding, the role of neurologists in COVID-19 is probably underrecognized. Objective: The aim of this study was to report the reasons for requesting neurological consultations by internists and intensivists in a COVID-19-dedicated hospital. Methods: This retrospective study was carried out at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brazil, a 900-bed COVID-19 dedicated center (including 300 intensive care unit beds). COVID-19 diagnosis was confirmed by SARS-CoV-2-RT-PCR in nasal swabs. All inpatient neurology consultations between March 23^rd and May 23^rd, 2020 were analyzed. Neurologists performed the neurological exam, assessed all available data to diagnose the neurological condition, and requested additional tests deemed necessary. Difficult diagnoses were established in consensus meetings. After diagnosis, neurologists were involved in the treatment. Results: Neurological consultations were requested for 89 out of 1,208 (7.4%) inpatient COVID admissions during that period. Main neurological diagnoses included: encephalopathy (44.4%), stroke (16.7%), previous neurological diseases (9.0%), seizures (9.0%), neuromuscular disorders (5.6%), other acute brain lesions (3.4%), and other mild nonspecific symptoms (11.2%). Conclusions: Most neurological consultations in a COVID-19-dedicated hospital were requested for severe conditions that could have an impact on the outcome. First-line doctors should be able to recognize neurological symptoms; neurologists are important members of the medical team in COVID-19 hospital care.

RESUMO

Introdução: Mais de um terço dos pacientes com COVID-19 apresentam sintomas neurológicos que variam de anosmia a AVC e encefalopatia. Além disso, doenças neurológicas prévias podem exigir tratamento especial e estar associadas a piores desfechos. Não obstante, o papel dos neurologistas na COVID-19 é provavelmente pouco reconhecido. Objetivo: O objetivo deste estudo foi relatar os motivos para solicitar consultas neurológicas por clínicos e intensivistas em um hospital dedicado à COVID-19. Métodos: Estudo retrospectivo realizado no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Brasil, um centro dedicado à COVID-19 com 900 leitos (incluindo 300 leitos para unidades de terapia intensiva). O diagnóstico de COVID-19 foi confirmado por SARS-CoV-2-RT-PCR em swabs nasais. Todas as interconsultas de neurologia hospitalar entre 23 de março e 23 de maio de 2020 foram analisadas. Os neurologistas realizaram o exame neurológico, avaliaram todos os dados disponíveis para diagnosticar a patologia neurológica e solicitaram exames adicionais conforme necessidade. Diagnósticos difíceis foram estabelecidos em reuniões de consenso. Após o diagnóstico, os neurologistas participaram da condução dos casos. Resultados: Foram solicitadas consultas neurológicas para 89 de 1.208 (7,4%) em pacientes internados por COVID-19 durante o período. Os principais diagnósticos neurológicos incluíram: encefalopatia (44,4%), acidente vascular cerebral (16,7%), doenças neurológicas prévias (9,0%), crises epilépticas (9,0%), transtornos neuromusculares (5,6%), outras lesões encefálicas agudas (3,4%) e outros sintomas leves inespecíficos (11,2%). Conclusões: A maioria das consultas neurológicas em um hospital dedicado à COVID-19 foi solicitada para condições graves que poderiam afetar o desfecho clínico. Os médicos na linha de frente devem ser capazes de reconhecer sintomas neurológicos. Os neurologistas são membros importantes da equipe médica no atendimento hospitalar à COVID-19.

Keywords:

Coronavirus Infections - COVID-19 - Neurology - Seizures - Stroke - Metabolic Encephalopathy - Neuromuscular Diseases

Palavras-chave:

Infecções por Coronavírus - COVID-19 - Neurologia - Convulsões - Acidente Vascular Cerebral - Encefalopatias - Doenças Neuromusculares

Authors’ contributions:

Studart-Neto and Guedes: conceptualized the paper, collected data, participated in consensus meetings, analyzed data and wrote the initial draft. They contributed equally to the present work. Tuma, Camelo Filho, Kubota, Iepsen, Moreira, Rodrigues, Ferrari, Carra, Spera, Oko, Lopes, Passos Neto, Dalben, de Souza, Baima, Ferreira da Silva, Moreno, Serafim Silva, Heise, Mendonça. Fortini, Smid, Adoni, Gonçalves, Pereira, Pinto, Gomes, Zanotelli, Brucki, Conforto, and Castro: collected data, participated in consensus meetings, reviewed the manuscript for important intellectual content. Nitrini: conceptualized the paper, participated in consensus meetings, wrote and reviewed the manuscript for intellectual content, supervised the study.

Publication History

Received: 22 June 2020

Accepted: 22 June 2020

Article published online:
13 June 2023

• References

• 1 Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020 Mar;368:m1036. https://doi.org/10.1136/bmj.m1036
• 2 Johns Hopkins University & Medicine. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available from: http://coronavirus.jhu.edu/map.html.
• 3 Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020 Jun;382(23):2268-70. https://doi.org/10.1056/NEJMc2008597
• 4 Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020 Jun. https://doi.org/10.1212/WNL.20200089202000899937
• 5 Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 Apr;77(6):683-90. https://doi.org/10.1001/jamaneurol.2020.1127
• 6 Aggarwal G, Lippi G, Henry BM. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature. Int J Stroke. 2020 Jun;15(4):385-9. https://doi.org/10.1177/1747493020921664
• 7 Yin R, Yang Z, Wei Y, Li Y, Chen H, Liu Z, et al. Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study. medRxiv. 2020. 2020.04.29.20085415. https://doi.org/10.1101/2020.04.29.20085415
• 8 Pranata R, Huang I, Lim MA, Wahjoepramono PEJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19 - systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020 May;29(8):104949. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104949
• 9 Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, et al. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020 May; 10.1212/WNL.20200089202000899848. https://doi.org/10.1212/WNL.20200089202000899848
• 10 Bhidayasiri R, Virameteekul S, Kim J-M, Pal PK, Chung S-J. COVID-19: an early review of its global impact and considerations for Parkinson’s disease patient care. J Mov Disord. 2020 Apr;13(2):105-14. https://doi.org/10.14802/jmd.20042
• 11 Kuroda N. Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav. 2020 Apr;108(2020):107122. https://doi.org/10.1016/j.yebeh.2020.107122
• 12 Bersano A, Pantoni L. On being a neurologist in Italy at the time of the COVID-19 outbreak. Neurology. Neurology. 2020 May;94(21):905-6. https://doi.org/10.1212/WNL.20200089202000899508
• 13 Majersik JJ, Reddy VK. Acute neurology during the COVID-19 pandemic: Supporting the front line. Neurology. 2020 Jun;94(24):1055-7. https://doi.org/10.1212/WNL.20200089202000899564
• 14 Sellner J, Taba P, Öztürk S, Helbok R. The need for neurologists in the care of COVID-19 patients. Eur J Neurol. 2020 Apr. https://doi.org/10.1111/ene.14257
• 15 Rubin MA, Bonnie RJ, Epstein L, Hemphill C, Kirschen M, Lewis A, et al. AAN position statement: The COVID-19 pandemic and the ethical duties of the neurologist. Neurology. 2020 May;10.1212/WNL.20200089202000899744. https://doi.org/10.1212/WNL.20200089202000899744
• 16 Radmanesh A, Raz E, Zan E, Derman A, Kaminetzky M. Brain imaging use and findings in COVID-19: A single academic center experience in the epicenter of disease in the United States. AJNR Am J Neuroradiol. 2020 May. https://doi.org/10.3174/ajnr.A6610
• 17 Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological features of Covid-19. N Engl J Med. 2020 Jun. https://doi.org/10.1056/NEJMc2019373
• 18 Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020 Mar;94(2020):55-58. https://doi.org/10.1016/j.ijid.2020.03.062
• 19 Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019 (COVID-19) and anosmia. JAMA Neurol. 2020 May. https://doi.org/10.1001/jamaneurol.2020.2125
• 20 Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020 Jul;92(7):699-702. https://doi.org/10.1002/jmv.25915
• 21 Dixon L, Varley J, Gontsarova A, Mallon D, Tona F, Muir D, et al. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm. 2020 May;7(5):e789. https://doi.org/10.1212/NXI.20200089202000890789
• 22 Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated Acute hemorrhagic necrotizing encephalopathy: CT and MRI Features. Radiology. 2020 Mar:201187. https://doi.org/10.1148/radiol.2020201187
• 23 Bernard-Valnet R, Pizzarotti B, Anichini A, Demars Y, Russo E, Schmidhauser M, et al. Two patients with acute meningo-encephalitis concomitant to SARS-CoV-2 infection. Eur J Neurol. 2020 Mar. https://doi.org/10.1111/ene.14298
• 24 Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Ann Neurol. 2020 May. https://doi.org/10.1002/ana.25783
• 25 Novi G, Rossi T, Pedemonte E, Saitta L, Rolla C, Roccatagliata L, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020 Jun;7(5):e797. https://doi.org/10.1212/NXI.20200089202000890797
• 26 Parsons T, Banks S, Bae C, Gelber J, Alahmadi H, Tichauer M. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020 May. https://doi.org/10.1007/s00415-020-09951-9
• 27 Munhoz RP, Pedroso JL, Nascimento FA, Almeida SM, Barsottini OGP, Cardoso FEC, et al. Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arq Neuropsiquiatr. 2020 Mar;78(5):290-300. https://doi.org/10.1590/0004-282x20200051